Delinia
Healthcare
HQ: Cambridge, United States
Investors: 1
Developed regulatory T-cell therapies for autoimmune diseases
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |
Developed regulatory T-cell therapies for autoimmune diseases
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |